FORWARD PHARMA A/S — CVR 28865880
Is this your company?
Verify ownership and add your website, description, services, products, logo, socials and more.
Claim & enrichReviews
Loading…
Verified reviews from Søge users
Ownership & management network
Building the network…
Colour = company status · blue dot = person · red border = tied to a bankruptcy. Double-click a company to open it; use the filters to narrow.
In liquidation
📅 Founded 2005
👥 5 employees
CVR
28865880
↗ Datacvr
Status
In liquidation
Company form
Public limited (A/S)
Start date
2005-07-01
Addresses
Strandvejen 125, 2900 Hellerup
(KØBENHAVN)
Employees
5
Employment interval
ANTAL_5_9
Advertising protected
Yes
Industry (3)
Forskning og udvikling inden for naturvidenskab og teknik
731000
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
721900
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
721000
Email (3)
PMA@forward-pharma.com
2012-05-08
art@forward-pharma.com
2015-09-17
investors@forward-pharma.com
2019-10-22
Phone Number (1)
33444242
2006-12-01
Website (1)
www.forward-pharma.com
2023-02-03
Fax (1)
33444244
Addresses (4)
Østergade 5, 3,
1100 København K
(KØBENHAVN)
2005-07-01
Nyhavn 43B, 2,
1051 København K
(KØBENHAVN)
2007-01-15
Østergade 24A, 1,
1100 København K
(KØBENHAVN)
2011-06-09
Strandvejen 125,
2900 Hellerup
(KØBENHAVN)
2023-09-15
Relations (33)
R.G. HOLDING A/S
Auditor
Profile
NORDIC BIOTECH K/S
FoundersLegal owner
Profile
Ownership: 20%
· Voting: 20%
KR 483 A/S
Auditor
Profile
JUT NR. 2180 A/S
Auditor
Profile
Christian Karsten Hansen
Board member
Profile
Claus Bo Søndergaard Svendsen
Director
Profile
Hans Thalsgård Schambye
Board member
Profile
FORWARD PHARMA A/S
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Jakob Mosegaard Larsen
Board memberLiquidator
Profile
Peder Møller Andersen
Director
Profile
NORDIC BIOTECH OPPORTUNITY FUND K/S
Legal owner
Profile
Ownership: 20%
· Voting: 20%
NB FP INVESTMENT K/S
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Florian Schønharting
ChairmanBoard member
Profile
Marianne Kock
Board member
Profile
Grant Hellier Lawrence
Board member
Profile
Morten Priskorn
Director
Profile
Lars Folke Henrik Nilsson
Board memberDirector
Profile
Wyle David Solomon
Chairman
Profile
John Kevin Buchi
Board member
Profile
Joel David Sendek
økonomidirektør
Profile
Johannes Gerardus Joseph van de Winkel
Board member
Profile
Torsten Goesch
Board member
Profile
Joel David Sendek
økonomidirektør
Profile
Rosetta Capital I, LP
Legal owner
Profile
Ownership: 15%
· Voting: 15%
The Bank of New York Mellon
Legal owner
Profile
Ownership: 20%
· Voting: 20%
Rupert Sandbrink
Director
Profile
Karen Lesley Smith
Board member
Profile
Duncan Moore
Board member
Profile
Ownership: 5%
· Voting: 5%
GEP II, L.P.
Legal owner
Profile
Ownership: 10%
· Voting: 10%
Mason Capital Master Fund, L.P.
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Nerine Trust Company Limited
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Lifecycle (1)
2005-07-01 — 2025-11-26
Employees per month
| Period | Employees | FTE (man-years) |
|---|---|---|
| 2025-09 | 2 | 2 |
| 2025-08 | 2 | 1.68 |
| 2025-07 | 2 | 1.52 |
| 2025-06 | 2 | 1.84 |
| 2025-05 | 2 | 1.76 |
| 2025-04 | 2 | 1.84 |
| 2025-03 | 4 | 4 |
| 2025-02 | 2 | 1.76 |
| 2025-01 | 2 | 1.6 |
| 2024-12 | 2 | 2 |
| 2024-11 | 2 | 1.68 |
| 2024-10 | 2 | 1.52 |
| 2024-09 | 4 | 4 |
| 2024-08 | 2 | 1.6 |
| 2024-07 | 2 | 1.52 |
| 2024-06 | 2 | 1.84 |
| 2024-05 | 2 | 1.68 |
| 2024-04 | 2 | 1.76 |
| 2024-03 | 2 | 1.84 |
| 2024-02 | 4 | 4 |
| 2024-01 | 2 | 1.6 |
| 2023-12 | 2 | 1.84 |
| 2023-11 | 2 | 1.6 |
| 2023-10 | 2 | 1.6 |
| 2023-09 | 4 | 4 |
| 2023-08 | 2 | 1.52 |
| 2023-07 | 2 | 1.68 |
| 2023-06 | 2 | 1.68 |
| 2023-05 | 2 | 1.76 |
| 2023-04 | 2 | 2 |
| 2023-03 | 4 | 4 |
| 2023-02 | 2 | 1.88 |
| 2023-01 | 2 | 1.8 |
| 2022-12 | 2 | 1.84 |
| 2022-11 | 2 | 1.8 |
| 2022-10 | 2 | 1.84 |
| 2022-09 | 4 | 4 |
| 2022-08 | 2 | 1.76 |
| 2022-07 | 2 | 1.84 |
| 2022-06 | 2 | 1.84 |
| 2022-05 | 2 | 1.88 |
| 2022-04 | 2 | 2 |
| 2022-03 | 4 | 4 |
| 2022-02 | 2 | 1.88 |
| 2022-01 | 2 | 1.84 |
| 2021-12 | 2 | 1.84 |
| 2021-11 | 2 | 1.8 |
| 2021-10 | 2 | 1.84 |
| 2021-09 | 4 | 4 |
| 2021-08 | 2 | 1.8 |
| 2021-07 | 2 | 1.8 |
| 2021-06 | 2 | 1.8 |
| 2021-05 | 2 | 1.92 |
| 2021-04 | 2 | 2 |
| 2021-03 | 4 | 4 |
| 2021-02 | 2 | 1.88 |
| 2021-01 | 2 | 1.88 |
| 2020-12 | 2 | 1.88 |
| 2020-11 | 2 | 1.84 |
| 2020-10 | 2 | 1.8 |
| 2020-09 | 2 | 1.8 |
| 2020-08 | 4 | 4 |
| 2020-07 | 2 | 1.76 |
| 2020-06 | 4 | 4 |
| 2020-05 | 2 | 1.92 |
| 2020-04 | 2 | 1.92 |
| 2020-03 | 4 | 4 |
| 2020-02 | 3 | 2 |
| 2020-01 | 3 | 2 |
| 2019-12 | 5 | 5 |
| 2019-11 | 3 | 2.4 |
| 2019-10 | 3 | 2 |
Production units (1)
Registration history
2025-11-26
Company ceased
2023-09-15
Addresses
2011-06-09
Addresses
2007-01-15
Addresses
2005-07-01
Addresses
2005-07-01
Name history: FORWARD PHARMA A/S
2005-07-01
Company registered
Attributes
ARKIV_REGISTRERINGSNUMMER
A/S352071
Purpose
Selskabets formål er direkte eller indirekte via datterselskaber at drive aktiviteter med udvikling, fremstilling, distribution og salg af lægemidler, og enhver anden relateret virksomhed efter bestyrelsens skøn. Herudover kan selskabet deltage i samarbejder eller indgå i partnerskaber med andre virksomheder inden for sit forretningsområde, herunder udlicensiere rettigheder inden for sit forretningsområde.
First financial period end
2006-12-31
First financial period start
2005-07-01
Registered capital
1,013,735 DKK; 1,014,735 DKK; 1,209,968 DKK; 1,273,769 DKK; 1,383,508 DKK; 1,457,907 DKK; 1,526,912 DKK; 1,577,045 DKK; 1,598,530 DKK; 1,608,666 DKK; 1,620,916 DKK; 1,633,586 DKK; 1,646,540 DKK; 1,655,381 DKK; 1,793,391 DKK; 1,800,981 DKK; 4,581,376 DKK; 4,651,374 DKK; 4,665,589 DKK; 4,687,173 DKK; 4,700,173 DKK; 4,714,388 DKK; 4,718,399 DKK; 500,000 DKK; 819,500 DKK; 943,679 DKK; 947,401 DKK; 950,738 DKK; 964,875 DKK; 966,283 DKK; 982,644 DKK; 992,765 DKK; 998,765 DKK
Share classes
No; No; No; No; No; No; No; No; No; No; No; No; No; No; No
Capital currency
DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK; DKK
Pseudo CVR number
No
REGISTRERING_LIKVIDATION
2025-02-25
Financial year end
31.12
Financial year start
01.01
Audit opted out
No
Signing rule
Selskabet tegnes (i) af bestyrelsens formand i forening med et bestyrelsesmedlem, (ii) af bestyrelsens formand i forening med et medlem af direktionen eller (iii) af den samlede bestyrelse.; Virksomheden tegnes af en likvidator
Latest articles date
2014-11-14; 2015-03-24; 2015-04-13; 2015-04-20; 2015-06-23; 2015-11-24; 2016-05-06; 2016-06-01; 2016-07-29; 2016-08-30; 2017-03-29; 2017-05-03; 2017-08-02; 2017-09-01; 2017-11-21; 2017-11-28; 2018-04-04; 2018-06-12; 2018-09-18; 2019-05-08; 2019-11-26; 2020-04-24; 2020-05-07; 2021-04-13; 2022-02-16; 2022-11-09; 2023-05-02; 2023-06-08; 2023-06-29; 2024-02-12; 2024-06-28
Similar companies
Searching...
Didn't find what you need? Try searching
Vehicles